aluates Reports

$ 0.0

Automative

Global mRNA COVID-19 Vaccine Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-2U15426

Global mRNA COVID 19 Vaccine Market Research Report 2023

BUY CHAPTERS

Global mRNA COVID-19 Vaccine Market Research Report 2025

Code: QYRE-Auto-2U15426

Report

May 2025

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Moderna, Inc

CanSino Biologicals

Pfizer Inc

Fosun Pharmaceutical

CSPC Pharmaceutical

mRNA COVID-19 Vaccine Market Size

The global market for mRNA COVID-19 Vaccine was valued at US$ 4148 million in the year 2024 and is projected to reach a revised size of US$ 4535 million by 2031, growing at a CAGR of 1.3% during the forecast period.

mRNA COVID-19 Vaccine Market

Messenger ribonucleic acid (mRNA) is a molecule that provides cells with instructions for making proteins. mRNA vaccines contain the instructions for making the SARS-CoV-2 spike protein. This protein is found on the surface of the virus that causes COVID-19. The mRNA molecule is essentially a recipe, telling the cells of the body how to make the spike protein. mRNA COVID-19 Vaccines are given by injection, usually into the muscle of the upper arm.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for mRNA COVID-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA COVID-19 Vaccine.

The mRNA COVID-19 Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global mRNA COVID-19 Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the mRNA COVID-19 Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of mRNA COVID-19 Vaccine Market Report

Report Metric	Details
Report Name	mRNA COVID-19 Vaccine Market
Accounted market size in year	US$ 4148 million
Forecasted market size in 2031	US$ 4535 million
CAGR	1.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Non-replicating mRNA Vaccine Self-amplifying mRNA Vaccine
Segment by Application	Children Adults
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Moderna, CanSino Biologicals, Pfizer, Fosun-Pharmaceutical, CSPC Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA COVID-19 Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA COVID-19 Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is mRNA COVID-19 Vaccine Market growing?

Ans: The mRNA COVID-19 Vaccine Market witnessing a CAGR of 1.3% during the forecast period 2025-2031.

What is the mRNA COVID-19 Vaccine Market size in 2031?

Ans: The mRNA COVID-19 Vaccine Market size in 2031 will be US$ 4535 million.

Who are the main players in the mRNA COVID-19 Vaccine Market report?

Ans: The main players in the mRNA COVID-19 Vaccine Market are Moderna, CanSino Biologicals, Pfizer, Fosun-Pharmaceutical, CSPC Pharmaceutical

What are the Application segmentation covered in the mRNA COVID-19 Vaccine Market report?

Ans: The Applications covered in the mRNA COVID-19 Vaccine Market report are Children, Adults

What are the Type segmentation covered in the mRNA COVID-19 Vaccine Market report?

Ans: The Types covered in the mRNA COVID-19 Vaccine Market report are Non-replicating mRNA Vaccine, Self-amplifying mRNA Vaccine

Recommended Reports

COVID-19 Vaccine Ecosystem

Flu & Vaccine Markets

mRNA & Viral Innovations

1 mRNA COVID-19 Vaccine Market Overview

1.1 Product Definition

1.2 mRNA COVID-19 Vaccine by Type

1.2.1 Global mRNA COVID-19 Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Non-replicating mRNA Vaccine

1.2.3 Self-amplifying mRNA Vaccine

1.3 mRNA COVID-19 Vaccine by Application

1.3.1 Global mRNA COVID-19 Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Children

1.3.3 Adults

1.4 Global mRNA COVID-19 Vaccine Market Size Estimates and Forecasts

1.4.1 Global mRNA COVID-19 Vaccine Revenue 2020-2031

1.4.2 Global mRNA COVID-19 Vaccine Sales 2020-2031

1.4.3 Global mRNA COVID-19 Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 mRNA COVID-19 Vaccine Market Competition by Manufacturers

2.1 Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global mRNA COVID-19 Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global mRNA COVID-19 Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of mRNA COVID-19 Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of mRNA COVID-19 Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of mRNA COVID-19 Vaccine, Product Type & Application

2.7 Global Key Manufacturers of mRNA COVID-19 Vaccine, Date of Enter into This Industry

2.8 Global mRNA COVID-19 Vaccine Market Competitive Situation and Trends

2.8.1 Global mRNA COVID-19 Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest mRNA COVID-19 Vaccine Players Market Share by Revenue

2.8.3 Global mRNA COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global mRNA COVID-19 Vaccine Market Scenario by Region

3.1 Global mRNA COVID-19 Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global mRNA COVID-19 Vaccine Sales by Region: 2020-2031

3.2.1 Global mRNA COVID-19 Vaccine Sales by Region: 2020-2025

3.2.2 Global mRNA COVID-19 Vaccine Sales by Region: 2026-2031

3.3 Global mRNA COVID-19 Vaccine Revenue by Region: 2020-2031

3.3.1 Global mRNA COVID-19 Vaccine Revenue by Region: 2020-2025

3.3.2 Global mRNA COVID-19 Vaccine Revenue by Region: 2026-2031

3.4 North America mRNA COVID-19 Vaccine Market Facts & Figures by Country

3.4.1 North America mRNA COVID-19 Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America mRNA COVID-19 Vaccine Sales by Country (2020-2031)

3.4.3 North America mRNA COVID-19 Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe mRNA COVID-19 Vaccine Market Facts & Figures by Country

3.5.1 Europe mRNA COVID-19 Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe mRNA COVID-19 Vaccine Sales by Country (2020-2031)

3.5.3 Europe mRNA COVID-19 Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific mRNA COVID-19 Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific mRNA COVID-19 Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific mRNA COVID-19 Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific mRNA COVID-19 Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America mRNA COVID-19 Vaccine Market Facts & Figures by Country

3.7.1 Latin America mRNA COVID-19 Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America mRNA COVID-19 Vaccine Sales by Country (2020-2031)

3.7.3 Latin America mRNA COVID-19 Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa mRNA COVID-19 Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa mRNA COVID-19 Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa mRNA COVID-19 Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa mRNA COVID-19 Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global mRNA COVID-19 Vaccine Sales by Type (2020-2031)

4.1.1 Global mRNA COVID-19 Vaccine Sales by Type (2020-2025)

4.1.2 Global mRNA COVID-19 Vaccine Sales by Type (2026-2031)

4.1.3 Global mRNA COVID-19 Vaccine Sales Market Share by Type (2020-2031)

4.2 Global mRNA COVID-19 Vaccine Revenue by Type (2020-2031)

4.2.1 Global mRNA COVID-19 Vaccine Revenue by Type (2020-2025)

4.2.2 Global mRNA COVID-19 Vaccine Revenue by Type (2026-2031)

4.2.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global mRNA COVID-19 Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global mRNA COVID-19 Vaccine Sales by Application (2020-2031)

5.1.1 Global mRNA COVID-19 Vaccine Sales by Application (2020-2025)

5.1.2 Global mRNA COVID-19 Vaccine Sales by Application (2026-2031)

5.1.3 Global mRNA COVID-19 Vaccine Sales Market Share by Application (2020-2031)

5.2 Global mRNA COVID-19 Vaccine Revenue by Application (2020-2031)

5.2.1 Global mRNA COVID-19 Vaccine Revenue by Application (2020-2025)

5.2.2 Global mRNA COVID-19 Vaccine Revenue by Application (2026-2031)

5.2.3 Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global mRNA COVID-19 Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Moderna

6.1.1 Moderna Company Information

6.1.2 Moderna Description and Business Overview

6.1.3 Moderna mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Moderna mRNA COVID-19 Vaccine Product Portfolio

6.1.5 Moderna Recent Developments/Updates

6.2 CanSino Biologicals

6.2.1 CanSino Biologicals Company Information

6.2.2 CanSino Biologicals Description and Business Overview

6.2.3 CanSino Biologicals mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CanSino Biologicals mRNA COVID-19 Vaccine Product Portfolio

6.2.5 CanSino Biologicals Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pfizer mRNA COVID-19 Vaccine Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Fosun-Pharmaceutical

6.4.1 Fosun-Pharmaceutical Company Information

6.4.2 Fosun-Pharmaceutical Description and Business Overview

6.4.3 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio

6.4.5 Fosun-Pharmaceutical Recent Developments/Updates

6.5 CSPC Pharmaceutical

6.5.1 CSPC Pharmaceutical Company Information

6.5.2 CSPC Pharmaceutical Description and Business Overview

6.5.3 CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 CSPC Pharmaceutical mRNA COVID-19 Vaccine Product Portfolio

6.5.5 CSPC Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 mRNA COVID-19 Vaccine Industry Chain Analysis

7.2 mRNA COVID-19 Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 mRNA COVID-19 Vaccine Production Mode & Process Analysis

7.4 mRNA COVID-19 Vaccine Sales and Marketing

7.4.1 mRNA COVID-19 Vaccine Sales Channels

7.4.2 mRNA COVID-19 Vaccine Distributors

7.5 mRNA COVID-19 Vaccine Customer Analysis

8 mRNA COVID-19 Vaccine Market Dynamics

8.1 mRNA COVID-19 Vaccine Industry Trends

8.2 mRNA COVID-19 Vaccine Market Drivers

8.3 mRNA COVID-19 Vaccine Market Challenges

8.4 mRNA COVID-19 Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Moderna, Inc

CanSino Biologicals

Pfizer Inc

Fosun Pharmaceutical

CSPC Pharmaceutical

List of Tables

Table 1. Global mRNA COVID-19 Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global mRNA COVID-19 Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global mRNA COVID-19 Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global mRNA COVID-19 Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global mRNA COVID-19 Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global mRNA COVID-19 Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global mRNA COVID-19 Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market mRNA COVID-19 Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of mRNA COVID-19 Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of mRNA COVID-19 Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of mRNA COVID-19 Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of mRNA COVID-19 Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global mRNA COVID-19 Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA COVID-19 Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global mRNA COVID-19 Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global mRNA COVID-19 Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global mRNA COVID-19 Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global mRNA COVID-19 Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global mRNA COVID-19 Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global mRNA COVID-19 Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global mRNA COVID-19 Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America mRNA COVID-19 Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America mRNA COVID-19 Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America mRNA COVID-19 Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America mRNA COVID-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America mRNA COVID-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe mRNA COVID-19 Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe mRNA COVID-19 Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe mRNA COVID-19 Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe mRNA COVID-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe mRNA COVID-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific mRNA COVID-19 Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific mRNA COVID-19 Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific mRNA COVID-19 Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific mRNA COVID-19 Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific mRNA COVID-19 Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America mRNA COVID-19 Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America mRNA COVID-19 Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America mRNA COVID-19 Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America mRNA COVID-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America mRNA COVID-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa mRNA COVID-19 Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa mRNA COVID-19 Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa mRNA COVID-19 Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa mRNA COVID-19 Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa mRNA COVID-19 Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global mRNA COVID-19 Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global mRNA COVID-19 Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global mRNA COVID-19 Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global mRNA COVID-19 Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global mRNA COVID-19 Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global mRNA COVID-19 Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global mRNA COVID-19 Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global mRNA COVID-19 Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global mRNA COVID-19 Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global mRNA COVID-19 Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global mRNA COVID-19 Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global mRNA COVID-19 Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global mRNA COVID-19 Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global mRNA COVID-19 Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global mRNA COVID-19 Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global mRNA COVID-19 Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Moderna Company Information

Table 71. Moderna Description and Business Overview

Table 72. Moderna mRNA COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Moderna mRNA COVID-19 Vaccine Product

Table 74. Moderna Recent Developments/Updates

Table 75. CanSino Biologicals Company Information

Table 76. CanSino Biologicals Description and Business Overview

Table 77. CanSino Biologicals mRNA COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. CanSino Biologicals mRNA COVID-19 Vaccine Product

Table 79. CanSino Biologicals Recent Developments/Updates

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer mRNA COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Pfizer mRNA COVID-19 Vaccine Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Fosun-Pharmaceutical Company Information

Table 86. Fosun-Pharmaceutical Description and Business Overview

Table 87. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Fosun-Pharmaceutical mRNA COVID-19 Vaccine Product

Table 89. Fosun-Pharmaceutical Recent Developments/Updates

Table 90. CSPC Pharmaceutical Company Information

Table 91. CSPC Pharmaceutical Description and Business Overview

Table 92. CSPC Pharmaceutical mRNA COVID-19 Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. CSPC Pharmaceutical mRNA COVID-19 Vaccine Product

Table 94. CSPC Pharmaceutical Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. mRNA COVID-19 Vaccine Distributors List

Table 98. mRNA COVID-19 Vaccine Customers List

Table 99. mRNA COVID-19 Vaccine Market Trends

Table 100. mRNA COVID-19 Vaccine Market Drivers

Table 101. mRNA COVID-19 Vaccine Market Challenges

Table 102. mRNA COVID-19 Vaccine Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of mRNA COVID-19 Vaccine

Figure 2. Global mRNA COVID-19 Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global mRNA COVID-19 Vaccine Market Share by Type: 2024 & 2031

Figure 4. Non-replicating mRNA Vaccine Product Picture

Figure 5. Self-amplifying mRNA Vaccine Product Picture

Figure 6. Global mRNA COVID-19 Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global mRNA COVID-19 Vaccine Market Share by Application: 2024 & 2031

Figure 8. Children

Figure 9. Adults

Figure 10. Global mRNA COVID-19 Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global mRNA COVID-19 Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global mRNA COVID-19 Vaccine Sales (2020-2031) & (K Units)

Figure 13. Global mRNA COVID-19 Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. mRNA COVID-19 Vaccine Report Years Considered

Figure 15. mRNA COVID-19 Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global mRNA COVID-19 Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest mRNA COVID-19 Vaccine Players: Market Share by Revenue in mRNA COVID-19 Vaccine in 2024

Figure 18. mRNA COVID-19 Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global mRNA COVID-19 Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America mRNA COVID-19 Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America mRNA COVID-19 Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe mRNA COVID-19 Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe mRNA COVID-19 Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific mRNA COVID-19 Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific mRNA COVID-19 Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America mRNA COVID-19 Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America mRNA COVID-19 Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa mRNA COVID-19 Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa mRNA COVID-19 Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Turkey mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE mRNA COVID-19 Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of mRNA COVID-19 Vaccine by Type (2020-2031)

Figure 51. Global Revenue Market Share of mRNA COVID-19 Vaccine by Type (2020-2031)

Figure 52. Global mRNA COVID-19 Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of mRNA COVID-19 Vaccine by Application (2020-2031)

Figure 54. Global Revenue Market Share of mRNA COVID-19 Vaccine by Application (2020-2031)

Figure 55. Global mRNA COVID-19 Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 56. mRNA COVID-19 Vaccine Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Vaccine Include COVID 19 Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

mRNA Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Messenger RNA Vaccines and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Vaccines Therapeutics Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Synthesis Manufacturing Market Research Report 2024

COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Covid 19 Vaccine Market Research Report 2024

Global Livestock mRNA Vaccines Market Research Report 2025

mRNA Vaccines for Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary mRNA Vaccines Market Research Report 2025

Global mRNA Vaccine Raw Materials Market Research Report 2024

Covid 19 Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Therapy Market Research Report 2024

Global mRNA Vaccine And Therapeutics Market Insights Forecast to 2030

COVID 19 Vaccines Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global mRNA Vaccine Core Enzyme Market Research Report 2025

Global COVID 19 Rapid Test Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions